{"id":595693,"date":"2026-08-25T16:54:22","date_gmt":"2026-08-25T16:54:22","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/595693\/"},"modified":"2026-08-25T16:54:22","modified_gmt":"2026-08-25T16:54:22","slug":"phylodynamics-and-evolution-of-the-2026-bundibugyo-virus-circulating-in-the-democratic-republic-of-the-congo-insights-from-a-100-day-window-of-genomic-sequencing-bundibugyo-ebolavirus","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/595693\/","title":{"rendered":"Phylodynamics and evolution of the 2026 Bundibugyo virus circulating in the Democratic Republic of the Congo: Insights from a 100\u2011day window of genomic sequencing &#8211; Bundibugyo ebolavirus"},"content":{"rendered":"<p>              <a name=\"p-2795-background-1\" class=\"anchor\" href=\"#p-2795-background-1\" aria-label=\"Heading link\"\/>Background<\/p>\n<p>Following up on <a href=\"https:\/\/virological.org\/t\/1045\" rel=\"nofollow noopener\" target=\"_blank\">our previous post<\/a>, we are continuing to sequence Bundibugyo virus (BDBV) genomes and performing phylodynamic analyses to understand how the current outbreak started and is unfolding.<\/p>\n<p>Laboratory diagnosis of Bundibugyo virus disease (BVD) and wet lab sequencing were performed as specified in previous posts: <a href=\"https:\/\/virological.org\/t\/1045\" class=\"inline-onebox\" rel=\"nofollow noopener\" target=\"_blank\">Genomic epidemiology of the ongoing 2026 Bundibugyo Virus Disease outbreak in the Democratic Republic of the Congo<\/a>. Briefly, clinical specimens included EDTA whole-blood samples from living patients and oral fluid specimens from deceased patients were collected from suspected cases of BVD in the Democratic Republic of the Congo (DRC). Specimens were analyzed at either (1) the Institut National de Recherche Biom\u00e9dicale (INRB), Kinshasa, (2) the Laboratoire Provincial de Sant\u00e9 Publique (LPSP, Provincial Public Health Laboratory), Ituri or (3) Decentralized laboratories located within Ebola treatment centers in Ituri province using the RADIONE Point-of-care system (KH Medical, Pyeongtaek-si, South Korea) and the RealStar Filovirus Screen RT-PCR kit 1.0 or 2.0 (Altona Diagnostics, Hamburg, Germany). We subsequently sequenced all PCR-positive samples with Cycle threshold (Ct) values &lt;31.<\/p>\n<p>We used the <a href=\"https:\/\/artic.network\/resources\/amplicon-nf\" rel=\"noopener nofollow ugc\" target=\"_blank\">amplicon-nf v.2 https:\/\/artic.network\/resources\/amplicon-nf<\/a> pipeline for consensus generation.<\/p>\n<p>A total of 626 genomes from 21 Health Zones in Ituri (n=625) and 1 Health Zone in Nord-Kivu (n=1) Provinces (Figure 1) were sequenced and have been deposited on <a href=\"http:\/\/pathoplexus.org\" rel=\"noopener nofollow ugc\" target=\"_blank\">pathoplexus.org<\/a>. Sampling dates span between 02-May-2026 and 9-Aug-2026. These can be accessed as Pathoplexus SeqSet BDBV_DRC_20260820 [<a href=\"https:\/\/pathoplexus.org\/seqsets\/PP_SS_3400.1\" class=\"inline-onebox\" rel=\"noopener nofollow ugc\" target=\"_blank\">PP_SS_3400.1 | Pathoplexus<\/a>].<\/p>\n<p>Figure 1 | Provinces (upper left) and Health Zones (upper right) with confirmed cases. Location of sampling of the 626 genomes described here (bottom left), with outlined area zoomed in further to the Health Zones with the most cases and genomes (bottom right). All but one genome are from Health Zones in Ituri Province with the remaining one from Katwa in Nord-Kivu.<\/p>\n<p><a name=\"p-2795-methods-2\" class=\"anchor\" href=\"#p-2795-methods-2\" aria-label=\"Heading link\"\/>Methods<\/p>\n<p>626 genomes <a href=\"https:\/\/pathoplexus.org\/seqsets\/PP_SS_3400.1\" rel=\"noopener nofollow ugc\" target=\"_blank\">Pathoplexus SeqSet BDBV_DRC_20260820<\/a> from DRC sampled between 2026-05-02 and 2026-08-09.<br \/>\n32 genomes were removed because they showed evidence of ADAR editing (Table 1).<br \/>\nAligned using MAFFT (<a href=\"https:\/\/doi.org\/10.1093\/nar\/gkf436\" rel=\"noopener nofollow ugc\" target=\"_blank\">Katoh et al, 2002<\/a>) \u2013 resulting alignment contained no indels.<br \/>\nThe alignment was trimmed to length 18,900 to remove sequencing artefacts at the end of the genome (one genome exhibited these: 26FHV054, PP_006XHL9.3).<br \/>\nMaximum likelihood tree using IQ-TREE 3 (<a href=\"https:\/\/doi.org\/10.1093\/molbev\/msag117\" rel=\"noopener nofollow ugc\" target=\"_blank\">Wong et al 2025<\/a>) (ModelFinder (<a href=\"https:\/\/doi.org\/10.1038\/nmeth.4285\" rel=\"noopener nofollow ugc\" target=\"_blank\">Kalyaanamoorthy et al, 2017<\/a>) selected the GTR+F+R3 substitution model) and with small branch lengths collapsed to zero.<br \/>\nThe phylogenetic tree was rooted to minimise residuals from the regression line. We identified genomes noticeably outside \u00b12 standard deviations of the residuals, removed the genomes, rerooted the tree to minimise residuals, and performed this series of steps a second time to remove one additional set of outliers, resulting in the cumulative removal of 69 genomes (Table 1).<br \/>\nTo infer the timescale and basic epidemiological characteristics of the data set we used BEAST X v10.6.0-beta2 (<a href=\"https:\/\/doi.org\/10.1038\/s41592-025-02751-x\" rel=\"noopener nofollow ugc\" target=\"_blank\">Baele et al 2025<\/a>). Two coalescent-based tree prior models were employed: exponential growth and the SkyGrid non-parametric model (<a href=\"https:\/\/doi.org\/10.1093\/molbev\/mss265\" rel=\"noopener nofollow ugc\" target=\"_blank\">Gill et al, 2013<\/a>) with 31 transition points at one week intervals and a cutoff of 32 weeks. A GTR model was employed with default priors and transition kernels. Runs were 100m steps, with 10,000 samples taken with a 10% burnin.<\/p>\n<p><a name=\"p-2795-results-3\" class=\"anchor\" href=\"#p-2795-results-3\" aria-label=\"Heading link\"\/>Results<\/p>\n<p>The maximum likelihood tree (Figure 2) exhibits a good temporal signal (Figure 3), with a regression slope of 7.9E-4. Our results indicate increased phylogenetic diversity relative to our previous analysis of 139 genomes [<a href=\"https:\/\/virological.org\/t\/1045\" class=\"inline-onebox\" rel=\"nofollow noopener\" target=\"_blank\">Genomic epidemiology of the ongoing 2026 Bundibugyo Virus Disease outbreak in the Democratic Republic of the Congo<\/a>], Our initial analysis included 96 genomes from Bunia and Rwampara and 9 from Mongbwalu, whereas we now include 308 from Bunia and Rwampara and 47 from Mongbwalu (Figure 2).<\/p>\n<p>We inferred an evolutionary rate of 8.5E-4 substitutions per site per year (95% highest posterior density interval [HPDI]: 7.3\u20139.8E-4) under the SkyGrid coalescent model, with a time of the most recent common ancestor (tMRCA) of 22 February 2026 (95% HPDI: 16 January 2026 \u2013 24 March 2026). Under this model (considering 32 one-week intervals) the epidemic shows exponential growth over this time period but with a time-varying rate, indicating a relatively slow start and then an increased rate of growth from March until June, after which the rate appears to decline (Figure 4).<\/p>\n<p>Assuming that exponential growth is constant from the tMRCA to the most recently sampled tip (9 August), the estimated doubling time is 21.0 days (95% HPDI: 15.0 \u2013 40.7) and the tMRCA estimate is pushed back to 21 January 2026 (95% HPDI: 14 December 2025 \u2013 20 February 2026). Note that the inferred rate of evolution is approximately the same under both models.<\/p>\n<p>Genomes from Mongbwalu appear to represent substantial diversity in the maximum likelihood phylogeny, as well as emerging from relatively deep parts of both the maximum likelihood and time-calibrated phylogenies (Figures 2, 5). The root age and Skygrid reconstruction are compatible with a slow start of the epidemic in Mongbwalu, followed by exportations and an increased growth rate as larger urban areas (e.g., Bunia) were seeded. These results would be concordant with epidemiological reports suggesting that Mongbwalu could have been a starting point for the outbreak (<a href=\"https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2026-DON602\" rel=\"noopener nofollow ugc\" target=\"_blank\">WHO, 2026<\/a>). Additionally, we find that genomic and phylogenetic diversity was maintained and increasing during the sampling period, without any indication of fitness-altering mutations or a particular lineage starting to dominate.<\/p>\n<p>We note there are fewer genomes sampled after mid-July (Figure 5), and these results should be understood as preliminary and taken with caution.<\/p>\n<p>Figure 2 | Maximum likelihood tree with tips colored by Health Zone of sampling. Genomes from the DRC but not from Bunia, Rwampara, or Mongbwalu are grouped together into a single category. <a href=\"https:\/\/peartree.live\/?treeUrl=https:\/\/raw.githubusercontent.com\/INRB-UMIE\/BDBV2026-Trees\/main\/BDBV_2026-08-19.DRC_n525.ml.ptree&amp;configUrl=https:\/\/raw.githubusercontent.com\/INRB-UMIE\/BDBV2026-Trees\/main\/BDBV_2026-08-19_n525.ml.config.json\" rel=\"noopener nofollow ugc\" target=\"_blank\">Show in PearTree<\/a>.<\/p>\n<p>Figure 3 | Root-to-tip plot of 525 genomes after removing 32 genomes with signatures of ADAR-editing and 69 genomes identified as outliers. The estimated rate of evolution is 7.9E-4 and a tMRCA of early February 2025, compatible with estimates from BEAST. The color scheme matches that of Figure 2.<\/p>\n<p>Figure 4 | A. Skygrid reconstruction of relative population size over time. The blue line shows the mean estimate, and the shaded region represents the 95% HPD interval. The heavy dashed line indicates the median tMRCA (22 February 2026), while the dotted line indicates the upper bound of the 95% HPD interval (24 March 2026); the lower bound (16 January 2026) coincides with the lower limit of the y-axis. The exponential growth reconstruction is shown in orange. A rug plot at the bottom of the panel shows the dates and frequency of genomes included in the analysis. B. Daily case counts (RT-qPCR positive) by symptom onset in Mongbwalu (red), Bunia and Rwamparu (green), the rest of Ituri (gold), and the rest of the DRC (grey).<\/p>\n<p>Figure 5 | Time-calibrated summary tree from the Skygrid analysis. The tMRCA is represented by a violin at the root, with the median indicated by a vertical green line, the 95% HPD by the larger grey violin, and the 50% HPD by the inner green violin. <a href=\"https:\/\/peartree.live\/?treeUrl=https:\/\/raw.githubusercontent.com\/INRB-UMIE\/BDBV2026-Trees\/main\/BDBV_2026-08-19.DRC_n525.Skygrid.ptree&amp;configUrl=https:\/\/raw.githubusercontent.com\/INRB-UMIE\/BDBV2026-Trees\/main\/BDBV_2026-08-19_n525.Skygrid.config.json\" rel=\"noopener nofollow ugc\" target=\"_blank\">Open in PearTree<\/a>.<\/p>\n<p><a name=\"p-2795-authors-4\" class=\"anchor\" href=\"#p-2795-authors-4\" aria-label=\"Heading link\"\/>Authors<\/p>\n<p>Key contributors to data collection\/molecular testing\/data interpretation\/whole genome sequencing\/bioinformatics analysis\/phylogenetic analysis, and manuscript writing:<\/p>\n<p><a name=\"p-2795-institut-national-de-recherche-biomdicale-inrb-kinshasa-drc-and-partners-5\" class=\"anchor\" href=\"#p-2795-institut-national-de-recherche-biomdicale-inrb-kinshasa-drc-and-partners-5\" aria-label=\"Heading link\"\/>Institut National de Recherche Biom\u00e9dicale (INRB), Kinshasa \u2013 DRC and partners<\/p>\n<p>Adrienne Amuri-Aziza (INRB, Kinshasa, DRC)<br \/>\nPrince Akil-Bandali (INRB, Kinshasa, DRC)<br \/>\nJonathan E. Pekar (University of Edinburgh, UK)<br \/>\nPascal Adroba Tandele (Laboratoire Provincial de Sant\u00e9 Publique, Ituri, DRC)<br \/>\nEddy Kinganda-Lusamaki (INRB, University of Kinshasa, Kinshasa, DRC; TransVIHMI, Universit\u00e9 de Montpellier, INSERM, IRD, Montpellier, France)<br \/>\nMoritz U.G. Kraemer (University of Oxford, UK)<br \/>\nOlga Ntumba-Tshitenge (World Health Organization Country Office, Kinshasa, DRC)<br \/>\nJohn O. Otshudiema (World Health Organization Regional Office for Africa, Brazzaville, Republic of Congo)<br \/>\nAmadou Mouctar Diallo (World Health Organization Country Office, Kinshasa, DRC)<br \/>\nPrincesse Paku-Tshambu (INRB, Kinshasa, DRC)<br \/>\nPhine Malengo-Olokakoy (Laboratoire Provincial de Sant\u00e9 Publique, Ituri, DRC)<br \/>\nRilia Ola-Mpumbe (INRB, Kinshasa, DRC)<br \/>\nNeema Kavugho-Sindani (Laboratoire Provincial de Sant\u00e9 Publique, Ituri, DRC)<br \/>\nAnge Ponga-Museme (INRB, Kinshasa, DRC)<br \/>\nGradi Luakanda-Ndelemo (INRB, Kinshasa, DRC)<br \/>\nEmmanuel Lokilo-Lofiko (INRB, Kinshasa, DRC)<br \/>\nDaan Jansen (Institute of Tropical Medicine, Antwerp, Belgium)<br \/>\nLievin Tibasima-Dhesa (Laboratoire Provincial de Sant\u00e9 Publique, Ituri, DRC)<br \/>\nMarcel Lola-Loway (Division Provinciale de la Sant\u00e9, Ituri, DRC)<br \/>\nBenjamin Djemba-Fundji (Laboratoire Provincial de Sant\u00e9 Publique, Ituri, DRC)<br \/>\nFran\u00e7ois Berocan-Underos (Laboratoire Provincial de Sant\u00e9 Publique, Ituri, DRC)<br \/>\nBerkias Bakambu-Nebape (Laboratoire Provincial de Sant\u00e9 Publique, Ituri, DRC)<br \/>\nFiston Cikaya-Kankolongo (INRB, Kinshasa, DRC)<br \/>\nJudith Tete-Sitra (INRB, Kinshasa, DRC)<br \/>\nPauline-Chlo\u00e9 Muswamba-Kayembe (INRB, Kinshasa, DRC)<br \/>\nRaphael Lumembe &#8211; Numbi (INRB, University of Kinshasa, Kinshasa, DRC)<br \/>\nJulie Tuenakoko-Kulumbula (INRB, Kinshasa, DRC)<br \/>\nNelson Kashali (INRB, Kinshasa, DRC)<br \/>\nDavid Isengelo-Sikatenda (INRB, Kinshasa, DRC)<br \/>\nLeBon Matendo-Kakina (INRB, Kinshasa, DRC)<br \/>\nJean-Claude Makangara-Cigolo (INRB, University of Kinshasa, Kinshasa, DRC; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland)<br \/>\nServet Kimbonza (INRB, Kinshasa, DRC)<br \/>\nElzedek Mabika-Bope (INRB, Kinshasa, DRC)<br \/>\nPatrick Mukadi-Kakoni (INRB, University of Kinshasa)<br \/>\nDaniel Mukadi-Bamuleka (INRB, University of Kinshasa, Laboratoires P2\/P3, Rodolphe-Merieux INRB-Goma, DRC)<br \/>\nDav Ebengo (INRB, INOHA, DRC)<br \/>\nNick Loman (University of Birmingham, UK)<br \/>\nSam Wilkinson (University of Birmingham, UK)<br \/>\nJosh Quick (University of Birmingham, UK)<br \/>\nChris Kent (University of Birmingham, UK)<br \/>\nSam Richardson (University of Birmingham, UK)<br \/>\nCharlotte Pratt (University of Birmingham, UK)<br \/>\nBernardo Gutierrez (University of Oxford, UK)<br \/>\nRenny Doig (Simon Fraser University, Canada)<br \/>\nCiara Judge (University of Oxford)<br \/>\nJoseph L.-H. Tsui (University of Oxford)<br \/>\nCaroline Colijn (Simon Fraser University, Canada)<br \/>\nEmma Hodcroft (University of Basel, Switzerland)<br \/>\nMartine Peeters (TransVIHMI, Universit\u00e9 de Montpellier, INSERM, IRD, Montpellier, France)<br \/>\nAhidjo Ayouba (TransVIHMI, Universit\u00e9 de Montpellier, INSERM, IRD, Montpellier, France)<br \/>\nEric Delaporte (TransVIHMI, Universit\u00e9 de Montpellier, INSERM, IRD, Montpellier, France)<br \/>\nCollins Kipngetich Tanui (Africa CDC)<br \/>\nJustus Nsio (Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia)<br \/>\nMarie-Roseline Belizaire (World Health Organization Regional Office for Africa, Brazzaville, Republic of Congo)<br \/>\nKevin K. Ari\u00ebn (Institute of Tropical Medicine, Antwerp, Belgium)<br \/>\nLaurens Liesenborghs (Institute of Tropical Medicine, Antwerp; KU Leuven, Leuven, Belgium)<br \/>\nGuy Baele (KU Leuven, Leuven, Belgium)<br \/>\n\u00c1ine O\u2019Toole (University of Edinburgh, UK)<br \/>\nChristian Happi (African Center of Excellence for Genomics of Infectious Diseases, Redeemer\u2019s University, Ede, Nigeria)<br \/>\nAnne Rimoin (Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, USA)<br \/>\nLisa E. Hensley (US Department of Agriculture, Manhattan, KS, USA)<br \/>\nSofonias Kifle Tessema (Gates Foundation)<br \/>\nYenew Kebede (Africa CDC)<br \/>\nLorenzo Subissi (WHO)<br \/>\nNicksy Gumede (WHO AFRO)<br \/>\nChristian Ngandu (Institut National de Sant\u00e9 Publique (INSP), Kinshasa, DRC)<br \/>\nPiet Maes (European Plotkin Institute for Vaccinology, Universit\u00e9 Libre de Bruxelles (ULB), Brussels, Belgium)<br \/>\nDieudonn\u00e9 Mwamba (Institut National de Sant\u00e9 Publique (INSP), Kinshasa, DRC)<br \/>\nPierre Akilimali (Institut National de Sant\u00e9 Publique (INSP), Kinshasa, DRC)<br \/>\nMiles W. Carroll (University of Oxford, Oxford, UK)<br \/>\nJason Kindrachuk (University of Manitoba, Winnipeg, Manitoba, Canada)<br \/>\nKoen Vercauteren (Institute of Tropical Medicine, Antwerp, Belgium)<br \/>\nSteve Ahuka-Mundeke (INRB, University of Kinshasa, Kinshasa, DRC)<br \/>\nJean-Jacques Muyembe-Tamfum (INRB, University of Kinshasa, Kinshasa, DRC)<br \/>\nAndrew Rambaut (University of Edinburgh, UK)<br \/>\nTony Wawina-Bokalanga (INRB, University of Kinshasa, Kinshasa, DRC; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium)<br \/>\nPlacide Mbala-Kingebeni (INRB, University of Kinshasa, Kinshasa, DRC; South African National Bioinformatics Institute, University of the Western Cape, South Africa).<\/p>\n<p><a name=\"p-2795-acknowledgments-and-funding-6\" class=\"anchor\" href=\"#p-2795-acknowledgments-and-funding-6\" aria-label=\"Heading link\"\/>Acknowledgments and Funding<\/p>\n<p>We thank the Ministry of Public Health, Hygiene and Social Welfare of the DRC. The authors gratefully acknowledge the ongoing support of the Africa Centers for Disease Control and Prevention (Africa CDC), the World Health Organization, and partner non-governmental organizations. We also acknowledge the support provided by the Unit\u00e9 de Gestion du Programme de D\u00e9veloppement du Syst\u00e8me de Sant\u00e9 (UG-PDSS), the Institute of Tropical Medicine (ITM) through Belgian Directorate-general for Development Cooperation and Humanitarian Aid (DGD FA5 project, the Culmen International LCC, the US CDC Atlanta, and the Agence Fran\u00e7aise de D\u00e9veloppement through the AFROSCREEN project (grant agreement CZZ3209), coordinated by ANRS Maladies Infectieuses \u00e9m\u00e9rgentes in partnership with Institut Pasteur and Institut de Recherche pour le D\u00e9veloppement, the French Ministry of Europe and Foreign Affairs through FEF programme and support provided by Institut de Recherche pour le D\u00e9veloppement. AREBO project funded by ANRS-MIE. A.A.-A is supported by a DGD sandwich PhD scholarship. N.L., S.W., J.Q., C.K., R.D., C.C., E.H., J.E.P., A.O\u2019T., A.R &amp; P.M-K. acknowledge the support of the Wellcome Trust through the ARTIC Network (award 313694\/Z\/24\/Z) and the Gates Foundation. M.U.G.K. acknowledges funding from The Rockefeller Foundation (PC-2022-POP-005, also A.R.), Health AI Programme from <a href=\"http:\/\/Google.org\" rel=\"noopener nofollow ugc\" target=\"_blank\">Google.org<\/a>, the Oxford Martin School Programmes in Pandemic Genomics &amp; Digital Pandemic Preparedness, European Union\u2019s Horizon Europe programme projects MOOD (#874850) and E4Warning (#101086640), Wellcome Trust grants 303666\/Z\/23\/Z, 226052\/Z\/22\/Z &amp; 228186\/Z\/23\/Z, the United Kingdom Research and Innovation (#APP8583), the Medical Research Foundation (MRF-RG-ICCH-2022-100069), UK International Development (301542-403), the Bill &amp; Melinda Gates Foundation grants (INV-063472, INV-090281, INV-103122) and Novo Nordisk Foundation (NNF24OC0094346). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission or the other funders. The authors are also grateful for the support of the John D. and Catherine T. MacArthur Foundation, Flu Lab, and a cohort of generous donors through TED\u2019s Audacious Project, including the ELMA Foundation, MacKenzie Scott, the Skoll Foundation, and Open Philanthropy. We also acknowledge Oxford Nanopore Technologies (ONT) for providing sequencing R10 flow cells that partially supported this work.<\/p>\n<p><a name=\"p-2795-statement-on-continuing-work-and-analyses-prior-to-publication-7\" class=\"anchor\" href=\"#p-2795-statement-on-continuing-work-and-analyses-prior-to-publication-7\" aria-label=\"Heading link\"\/>Statement on continuing work and analyses prior to publication<\/p>\n<p>Please note that this data is based on work in progress and should be considered preliminary. Our analyses are ongoing, and a publication communicating our findings is in preparation. Sequences are publicly accessible under the Pathoplexus \u2018Restricted\u2019 licence and we would be grateful if the terms of this were respected. If you intend to use our data prior to our publication, please contact Dr Tony Wawina-Bokalanga (INRB, DRC) and\/or Prof. Placide Mbala-Kingebeni (INRB, DRC).<\/p>\n<p><a name=\"p-2795-appendix-8\" class=\"anchor\" href=\"#p-2795-appendix-8\" aria-label=\"Heading link\"\/>Appendix<\/p>\n<p>Table 1 | Genomes excluded from phylogenetic analysis and reason for exclusion.<\/p>\n<p>Sample ID<br \/>\nAccession<br \/>\nReason*<\/p>\n<p>BIA-1299<br \/>\nPP_00764QW<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-2971<br \/>\nPP_007AFQB<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-3038<br \/>\nPP_007A56Q<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-3217<br \/>\nPP_007AF2N<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-3599<br \/>\nPP_007AED1<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-3664<br \/>\nPP_007AEKN<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-3669<br \/>\nPP_007AENG<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4180<br \/>\nPP_007C78E<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4301<br \/>\nPP_007ESCH<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4482<br \/>\nPP_007ESDF<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4581<br \/>\nPP_007ESAM<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4627<br \/>\nPP_007ESBK<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4708<br \/>\nPP_007ESED<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4731<br \/>\nPP_007ES9P<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4768<br \/>\nPP_007ESFB<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4782<br \/>\nPP_007BZQR<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4836<br \/>\nPP_007ES4Z<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4855<br \/>\nPP_007ES5X<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4863<br \/>\nPP_007ES6V<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4864<br \/>\nPP_007ES7T<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4877<br \/>\nPP_007ES8R<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-4931<br \/>\nPP_007ESG9<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-5188<br \/>\nPP_007ERNX<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-5226<br \/>\nPP_007C6F1<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-5237<br \/>\nPP_007C4RG<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-5245<br \/>\nPP_007C4TC<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-5637<br \/>\nPP_007BXK3<br \/>\nSignatures of ADAR editing<\/p>\n<p>BIA-6194<br \/>\nPP_007EXUD<br \/>\nSignatures of ADAR editing<\/p>\n<p>MG-0747<br \/>\nPP_007EWH2<br \/>\nSignatures of ADAR editing<\/p>\n<p>MG-0881<br \/>\nPP_007EYF5<br \/>\nSignatures of ADAR editing<\/p>\n<p>NIZ-141<br \/>\nPP_007C74N<br \/>\nSignatures of ADAR editing<\/p>\n<p>NIZ-37<br \/>\nPP_007C6X2<br \/>\nSignatures of ADAR editing<\/p>\n<p>26FHV0224<br \/>\nPP_0075Z66<br \/>\nOutlier, +ve<\/p>\n<p>26FHV0325<br \/>\nPP_0075ZAY<br \/>\nOutlier, +ve<\/p>\n<p>BIA-1345<br \/>\nPP_00764TQ<br \/>\nOutlier, +ve<\/p>\n<p>BIA-1621<br \/>\nPP_00765FE<br \/>\nOutlier, -ve<\/p>\n<p>BIA-2075<br \/>\nPP_0076518<br \/>\nOutlier, +ve<\/p>\n<p>BIA-2408<br \/>\nPP_007A4G5<br \/>\nOutlier, +ve<\/p>\n<p>BIA-2476<br \/>\nPP_007A4LW<br \/>\nOutlier, +ve<\/p>\n<p>BIA-2576<br \/>\nPP_007A2K0<br \/>\nOutlier, -ve<\/p>\n<p>BIA-2871<br \/>\nPP_007A510<br \/>\nOutlier, -ve<\/p>\n<p>BIA-2883<br \/>\nPP_007A38N<br \/>\nOutlier, +ve<\/p>\n<p>BIA-3476<br \/>\nPP_007A62X<br \/>\nOutlier, +ve<\/p>\n<p>BIA-3668<br \/>\nPP_007AEMJ<br \/>\nOutlier, +ve<\/p>\n<p>BIA-3706<br \/>\nPP_007A6CB<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4155<br \/>\nPP_007C7AA<br \/>\nOutlier, +ve<\/p>\n<p>BIA-4271<br \/>\nPP_007BXZ9<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4293<br \/>\nPP_007BY15<br \/>\nOutlier, +ve<\/p>\n<p>BIA-4304<br \/>\nPP_007BY23<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4310<br \/>\nPP_007BY31<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4312<br \/>\nPP_007BY5X<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4336<br \/>\nPP_007BY6V<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4352<br \/>\nPP_007BY8R<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4382<br \/>\nPP_007C7MM<br \/>\nOutlier, +ve<\/p>\n<p>BIA-4472<br \/>\nPP_007BZ8Q<br \/>\nOutlier, +ve<\/p>\n<p>BIA-4647<br \/>\nPP_007BWNY<br \/>\nOutlier, +ve<\/p>\n<p>BIA-4683<br \/>\nPP_007BYBK<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4709<br \/>\nPP_007BZJ3<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4780<br \/>\nPP_007BZPT<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4879<br \/>\nPP_007BYPU<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4881<br \/>\nPP_007BYTL<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4883<br \/>\nPP_007BYUJ<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4943<br \/>\nPP_007C5W5<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4973<br \/>\nPP_007C61V<br \/>\nOutlier, -ve<\/p>\n<p>BIA-4996<br \/>\nPP_007C66K<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5022<br \/>\nPP_007C68F<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5047<br \/>\nPP_007BYZ8<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5059<br \/>\nPP_007BZ30<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5063<br \/>\nPP_007BZ6U<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5074<br \/>\nPP_007ERSP<br \/>\nOutlier, +ve<\/p>\n<p>BIA-5075<br \/>\nPP_007ERRR<br \/>\nOutlier, +ve<\/p>\n<p>BIA-5093<br \/>\nPP_007C6E3<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5246<br \/>\nPP_007C4UA<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5284<br \/>\nPP_007C76J<br \/>\nOutlier, -ve<\/p>\n<p>BIA-532<br \/>\nPP_0076435<br \/>\nOutlier, +ve<\/p>\n<p>BIA-5376<br \/>\nPP_007BWTN<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5577<br \/>\nPP_007C50Y<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5587<br \/>\nPP_007C51W<br \/>\nOutlier, +ve<\/p>\n<p>BIA-5588<br \/>\nPP_007C52U<br \/>\nOutlier, +ve<\/p>\n<p>BIA-5589<br \/>\nPP_007C53S<br \/>\nOutlier, +ve<\/p>\n<p>BIA-5615<br \/>\nPP_007C57J<br \/>\nOutlier, +ve<\/p>\n<p>BIA-5629<br \/>\nPP_007BXJ5<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5697<br \/>\nPP_007BXRR<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5714<br \/>\nPP_007BXSP<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5722<br \/>\nPP_007BXTM<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5735<br \/>\nPP_007BXUK<br \/>\nOutlier, -ve<\/p>\n<p>BIA-5955<br \/>\nPP_007ERZ9<br \/>\nOutlier, -ve<\/p>\n<p>BIA-6012<br \/>\nPP_007C5HX<br \/>\nOutlier, +ve<\/p>\n<p>BIA-6019<br \/>\nPP_007C5KT<br \/>\nOutlier, -ve<\/p>\n<p>BIA-6363<br \/>\nPP_007ET22<br \/>\nOutlier, +ve<\/p>\n<p>BIA-6448<br \/>\nPP_007ESRQ<br \/>\nOutlier, +ve<\/p>\n<p>BIA-6455<br \/>\nPP_007ESVG<br \/>\nOutlier, +ve<\/p>\n<p>BIA-6463<br \/>\nPP_007ESWE<br \/>\nOutlier, +ve<\/p>\n<p>BIA-6466<br \/>\nPP_007ESXC<br \/>\nOutlier, +ve<\/p>\n<p>BIA-6763<br \/>\nPP_007EY8K<br \/>\nOutlier, +ve<\/p>\n<p>MG-0073<br \/>\nPP_007EVWB<br \/>\nOutlier, +ve<\/p>\n<p>MG-0624<br \/>\nPP_007EW7P<br \/>\nOutlier, +ve<\/p>\n<p>MG-0705<br \/>\nPP_007EWDB<br \/>\nOutlier, +ve<\/p>\n<p>MG-0738<br \/>\nPP_007EWG5<br \/>\nOutlier, +ve<\/p>\n<p>MG-0811<br \/>\nPP_007EWPQ<br \/>\nOutlier, +ve<\/p>\n<p>NIZ-146<br \/>\nPP_007C6Y0<br \/>\nOutlier, -ve<\/p>\n<p>Genomes are excluded due to an excess of T-&gt;C mutations in short spans characteristic of putative ADAR editing, or because they lie outside two stderr above the regression line (+ve) or below (-ve).<\/p>\n","protected":false},"excerpt":{"rendered":"Background Following up on our previous post, we are continuing to sequence Bundibugyo virus (BDBV) genomes and performing&hellip;\n","protected":false},"author":2,"featured_media":595694,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[163,85,46],"class_list":["post-595693","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-il","tag-israel"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/595693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=595693"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/595693\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/595694"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=595693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=595693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=595693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}